期刊文献+

穿膜肽-EGFP融合蛋白的表达、纯化与鉴定 被引量:4

Expression,purification and identification of CPPs-EGFP fusion protein
下载PDF
导出
摘要 目的构建EGFP-CPPs融合基因载体,表达、纯化并鉴定EGFP-CPPs融合蛋白。方法通过碱基合成的方法合成含有CPPs基因序列的EGFP上游引物,PCR扩增后收集CPPs-EGFP融合基因片段并电泳鉴定,将融合基因表达载体转染大肠杆菌并扩增表达,收集表达蛋白后过层析柱纯化,蛋白电泳检测表达蛋白分子质量,蛋白飞行质谱分析检测蛋白序列,体外细胞实验验证其穿膜功能。结果电泳检测可见与CPPs-EGFP分子质量对应的电泳条带,构建质粒测序含有目的基因序列。蛋白电泳检测到纯度较高的融合蛋白,其蛋白序列与目的序列一致。体外细胞实验证实了融合蛋白的穿膜功能。结论成功制备了具有穿膜功能的CPPs-EGFP融合蛋白,为其促进抗体-蛋白微球偶联物进入肿瘤细胞发挥治疗作用的研究奠定了基础。 Objective To construct EGFP-CPPs fusion genetic carrier,express,purify and identify EGFP-CPPs fusion protein.Methods Upstream primer containing CPPs gene sequence of green fluorescent was synthesized by basic radical synthesise methods.CPPs-EGFP fusion gene fragment was amplificatied by PCR methods and then indentified by electrophoresis.Bacillus coli were transfected with the fusion gene express vector and the fusion gene was amplificated and expressed.Fusion protein was collected and purified by column chromatography.Protein molecular mass was detected by protein electrophoresis.Protein sequence was detected by TOF analysis.Cell-penetrating function was tested by cell experiment in vitro.Results Electrophoresis site corresponding to EGFP-CPPs was displayed in electrophoresis;The gene sequence of constructed plasmid contained the target gene sequence.Purified fusion protein was displayed in protein electrophoresis.Protein sequence was in accord with interested protein sequence.CPPs-EGFP fusion protein displayed Cell-penetrating function in vitro.Conclusion CPPs-EGFP fusion protein with cell-penetrating function was successfully prepared in the experiment.It is a solid plateform to support the study of bringing antibody-albumin nanosphere conjugate into tumor cell with potertial therapeutical effect.
出处 《基础医学与临床》 CSCD 北大核心 2010年第9期902-906,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(30700836) 中国博士后科学基金(20070420152)
关键词 穿膜肽 增强型绿色荧光蛋白 膀胱肿瘤 CPPs EGFP bladder tumor
  • 相关文献

参考文献9

  • 1Heitz F, Morris MC, Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics [J].BrJPharmacol, 2009,157(2):195-206.
  • 2Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of ceil-penetrating peptides for medical and biological applications[J]. Adv Drug Deliv Rev, 2009, 61 ( 11 ) : 953 - 964.
  • 3Green M,Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein [J]. Cell, 1988, 55( 6 ) : 1179 - 1188.
  • 4Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells [ J ]. Proc Natl Acad Sci USA, 1994, 91 (2) :664 -668.
  • 5Ho A,Schwarze SR, Mermelstein SJ,et al. Synthetic protein transduction domains: enhanced transduction potential in vitro and invivo[J]. Cancer Res, 2001, 61(2):474-477.
  • 6Kashiwagi H, McDunn JE, Goedegebuure PS, et al. TAT-Bim induces extensive apoptosis in cancer cells [ J]. Ann Surg Oncol,2007, 14(5) : 1763 - 1771.
  • 7Mae M, Andaloussi SE, Lehto T, et al. Chemically modified cell-penetrating peptides for the delivery of nucleic acids[J]. Expert Opin Drug Deliv, 2009, 6( 11 ):1195 - 1205.
  • 8董晓,王家宁,唐俊明,潘国栋,黄永章,杨建业,曹书芬.细胞穿透肽PEP-1介导增强型绿色荧光蛋白在小鼠体内跨膜转导[J].基础医学与临床,2007,27(7):798-801. 被引量:7
  • 9Aroui S, Brahim S, Kenani A. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin cou- pled to cell penetrating peptides in different cell lines: a comparative Study [ J]. Biochem Biophys Res Commun, 2010, 391(1) :419 -425.

二级参考文献10

  • 1董晓,王家宁,黄永章,郭凌郧.pET15b-EGFP原核表达载体的构建及其表达和纯化[J].郧阳医学院学报,2005,24(6):321-325. 被引量:19
  • 2董晓,王家宁,黄永章,郭凌郧.PEP-1-EGFP融合蛋白的表达和纯化及其转导入人脐静脉内皮细胞[J].南方医科大学学报,2006,26(8):1114-1117. 被引量:5
  • 3Morris MC, Depollier J, Mery J, et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells [ J]. Nat Biotechnol, 2001, 19 (12) : 1173 - 1176.
  • 4Snyder EL, Dowdy SF. Cell penetrating peptides in drug delivery[J]. Pharm Res,2004, 21 (3) :389 -393.
  • 5Schwarze SR, Ho A, Vocero-Akbani A, et al. In vivo protein transduction: delivery of a biologically active protein into the mouse[J]. Science, 1999,285 (5433) : 1569 - 1572.
  • 6Snyder EL, Meade BR, Dowdy SF. Anti-cancer protein transduction strategies : reconstitution of p27 tumor suppressor function[J]. J Control Release, 2003, 91 ( 1 -2) :45 -51.
  • 7Roy I, Holle L, Song W, et al. Efficient translocation and apoptosis induction by adenovirus encoded VP22 - p53 fusion protein in human tumor cells in vitro [ J ]. Anticancer Res, 2002, 22(6A) :3185 -3189.
  • 8Park J, Ryu J, Kim KA, et al. Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells [ J ]. J Gen Virol, 2002, 83 ( Pt 5) :1173 - 1181.
  • 9Schwarze SR, Hmska KA, Dowdy SF. Protein transduction: unrestricted delivery into all cells? [J]. Trends Cell Biol, 2000,10(7) : 290 -295.
  • 10Cai SR, Xu G, Becker-Hapak M, et al. The kinetics and tissue distribution of protein transduction in mice[J]. Eur J Pharm Sci, 2006, 27(4) :311 -319.

共引文献6

同被引文献33

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部